27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Gainers
• HEXO, Inc. (NYSE:HEXO) stock increased by 27.45% to $1.30 during Thursday's pre-market session. The most recent rating by Roth Capital, on Mar 31, is at Neutral, with a price target of $1.
• Onconova Therapeutics, Inc. (NASDAQ:ONTX) shares increased by 25.78% to $0.60.
• Viveve Medical, Inc. (NASDAQ:VIVE) shares increased by 18.78% to $0.86.
• Sorrento Therapeutics, Inc. (NASDAQ:SRNE) shares rose 11.23% to $5.05. The most recent rating by Dawson James, on May 26, is at Buy, with a price target of $24.
• Aileron Therapeutics, Inc. (NASDAQ:ALRN) shares increased by 10.40% to $1.38. The most recent rating by HC Wainwright & Co., on Jun 5, is at Buy, with a price target of $2.
• FSD Pharma, Inc. (NASDAQ:HUGE) stock moved upwards by 10.21% to $5.29.
• Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) stock rose 9.05% to $2.53.
• Strata Skin Sciences, Inc. (NASDAQ:SSKN) shares increased by 8.80% to $1.36. According to the most recent rating by HC Wainwright & Co., on Mar 17, the current rating is at Neutral.
• AnaptysBio, Inc. (NASDAQ:ANAB) stock rose 8.25% to $21.92. The most recent rating by Credit Suisse, on May 7, is at Neutral, with a price target of $16.
• Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) shares moved upwards by 8.06% to $5.90. The most recent rating by HC Wainwright & Co., on May 19, is at Buy, with a price target of $12.
Losers
• Mustang Bio, Inc. (NASDAQ:MBIO) shares declined 24.13% to $3.49 during Thursday's pre-market session. The most recent rating by Oppenheimer, on May 12, is at Outperform, with a price target of $13.
• Immuron, Inc. (NASDAQ:IMRN) shares fell 24.09% to $7.50.
• Trxade Group, Inc. (NASDAQ:MEDS) stock fell 16.67% to $5.50.
• Intec Pharma, Inc. (NASDAQ:NTEC) stock declined 13.86% to $0.35.
• Dynatronics, Inc. (NASDAQ:DYNT) stock fell 13.66% to $0.85. The most recent rating by Aegis Capital, on May 19, is at Buy, with a price target of $1.
• Check-Cap, Inc. (NASDAQ:CHEK) stock fell 12.49% to $0.55. The most recent rating by H.C. Wainwright, on Apr 24, is at Buy, with a price target of $2.
• Avinger, Inc. (NASDAQ:AVGR) stock fell 11.54% to $0.46. The most recent rating by Aegis Capital, on May 15, is at Buy, with a price target of $1.
• Milestone Pharmaceuticals, Inc. (NASDAQ:MIST) shares decreased by 11.11% to $4. According to the most recent rating by Jefferies, on Mar 25, the current rating is at Hold.
• NeuroMetrix, Inc. (NASDAQ:NURO) shares decreased by 11.06% to $1.85.
• Xenetic Biosciences, Inc. (NASDAQ:XBIO) shares declined 10.69% to $1.17.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!